Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
investing
3
×
life sciences
national blog main
national top stories
cancer drugs
deals
new york blog main
new york top stories
san francisco blog main
san francisco top stories
third rock ventures
venture capital
acute myeloid leukemia
alx oncology
amgen
antisense oligonucleotide
autoimmune diseases
benzodiazepines
berkeley lights
biogen
biotech ipos
blackstone group
blackstone life sciences
boston
cancer
cancer immunotherapy
cd47
chronic kidney disease
cobimetinib
columbia university
david goldstein
deerfield healthcare technology acquisitions
deerfield management company
depression
epi4k
epilepsy
What
research
3
×
ipo
medicines
new
aims
arrival
backed
biotech
cancer
cause
ceo
companies
days
despite
drug
drugs
epilepsy
family
genes
genetic
hardest
hasn’t
hit
hottest
hunters
industry
ipos
life
links
marcio
market
momentum
mutations
neuro
praxis
precision
proteins
raised
ras
reels
Language
unset
3
×
Current search:
investing
×
research
×
unset
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer